Carson Wealth (CWM LLC)
ARTL icon

Carson Wealth (CWM LLC)’s Artelo Biosciences ARTL Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8 Buy
+1
New +$5 ﹤0.01% 5647
2025
Q4 		– Hold
0
– – – 5362

Other funds holding ARTL

AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ARTL Position: Q1 2026 in Review

Carson Wealth (CWM LLC) opened a new position in Artelo Biosciences (ARTL) in Q1 2026: 1 share worth $8. The stake represents ﹤0.01% of the portfolio and ranks #5647 among its holdings.

11 funds tracked by Wall St. Rank hold ARTL as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1 share of Artelo Biosciences worth $8 as of Q1 2026.
  • Artelo Biosciences was a new Carson Wealth (CWM LLC) position in Q1 2026.
  • Artelo Biosciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5647 holding.
  • 11 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.